Invention Grant
US08664265B2 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
有权
稳定的剂量形式的螺和脱甲基-1,2,4-三恶烷抗疟药
- Patent Title: Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
- Patent Title (中): 稳定的剂量形式的螺和脱甲基-1,2,4-三恶烷抗疟药
-
Application No.: US13183119Application Date: 2011-07-14
-
Publication No.: US08664265B2Publication Date: 2014-03-04
- Inventor: Arno Appavoo Enose , Harish Kumar Madan , Sumit Madan , Anupam Trehan , Puneet Tyagi , Vinod Kumar Arora
- Applicant: Arno Appavoo Enose , Harish Kumar Madan , Sumit Madan , Anupam Trehan , Puneet Tyagi , Vinod Kumar Arora
- Applicant Address: IN New Delhi
- Assignee: Ranbaxy Laboratories Limited
- Current Assignee: Ranbaxy Laboratories Limited
- Current Assignee Address: IN New Delhi
- Priority: IN1279/2005 20050518; IN1192/2006 20060512
- Main IPC: A61K31/357
- IPC: A61K31/357 ; C07D493/20
Abstract:
The field of the invention relates to stable dosage forms comprising spiro or dispiro 1,2,4-trioxolane antimalarials, or their pharmaceutically acceptable salts, prodrugs and analogues, and processes for their preparation. The water content of the dosage form is not more than 6.5% w/w.
Public/Granted literature
- US20120183607A1 STABLE DOSAGE FORMS OF SPIRO AND DISPIRO 1,2,4-TRIOXOLANE ANTIMALARIALS Public/Granted day:2012-07-19
Information query
